Introduction

Lymphocytic infundibuloneurohypophysitis (LINH)
is an inflammatory state in the posterior pituitary lobe that manifests itself in diabetes insipidus and often develops crucial panhypopituitarism [1] [2] [3] [4] [5] . Diagnosis of LINH is complicated because pituitary biopsy for diagnosis often causes serious complications [4, 5] . Since autoimmunity is thought to be the underlying cause, steroid therapy is recommended for LINH [6, 7] . Nevertheless, complete recovery of posterior pituitary function is hardly obtained, and long-term information is seldom available [4, 5] . To elucidate these issues, we report a case of LINH appropriately treated with steroid in the long-term followup with useful markers.
Case Report
A 65-year-old woman suffering from an acute development of polyuria and polydipsia was admitted to our hospital in 2002. Urine volume was 4,500 ml/day. Four weeks before admission, she was well and not taking any medication. She was 150 cm in height and 50.2 kg in weight. She had lost 2 kg during the last month. Blood pressure was 126/80 mm Hg. Body temperature was 36.4 ° C. Heart and chest sounds were normal.
She showed elevated serum osmolality of 305 mosm/kg H 2 O and low urine osmolality of 101 mosm/kg H 2 O. Serum sodium level was 150 mmol/l. Plasma antidiuretic hormone concentration was subnormal: 0.45 pg/ml (normal range 0.3-4.2). All anterior pituitary hormones were within normal limits, except for high serum prolactin (PRL) concentration, 37.3 ng/ml (normal range 5-15). Both antipituitary cell antibodies and antipituitary cell surface antibodies in serum were negative. Antinuclear antibody was negative. Diabetes mellitus was ruled out because of normal fast-
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Magnetic resonance imaging (MRI) of the pituitary gland revealed a marked nodular thickening of the neurohypophysis, with swelling of the hypophyseal stalk and the infundibulum ( fig. 1 a) . They were enhanced homogeneously after injection of Gd-DTPA ( fig. 1 b) . A normal hyperintense signal in the neurohypophysis was absent in T 1 -weighted images. Numerous diseases, including tumoral diseases, infectious diseases, and diabetes insipidus were ruled out by clinical state, MR images, and CSF results without abnormal cells. Langerhans cell histiocytosis and other granulomatous diseases such as sarcoidosis and Wegener's granulomatosis were less likely. Based on the clinical manifestation, findings of pituitary MRI and endocrinological and CSF examinations, the patient was diagnosed as having central diabetes insipidus possibly due to LINH [4, 5, 8, 9] . Treatment with prednisolone (PSL, 1 mg/kg/day, p.o.) and nasal drip of D -deaminovasopressin (DDAVP, 5 g/day) were started together ( fig. 2 ). Serum and urine osmolality were normalized with DDAVP. The amount of PSL was gradually decreased every 2 weeks (approximately 10% reduction of previous dosage). DDAVP was unnecessary 25 weeks after initial treatment; however, PSL was continued 7 weeks thereafter, following our protocol. Plasma concentration of IL-6 decreased to 12.9 pg/ml 10 days after the PSL treatment. At 10 weeks, PRL had decreased to 25.5 ng/ml ( fig. 2 ) . At 30 weeks, both PRL and IL-6 concentration were normalized to 8.2 and 3.8 pg/ml, respectively. Even 7 years after cessation of steroid, recurrence has not been observed in MRI examinations, and whole pituitary function is preserved.
Examination with an MRI 10 days after the beginning of PSL administration showed a dramatic improvement of the infundibular and pituitary thickening with a reappearance of the T 1 -weighted hyperintense signal in the neurohypophysis ( fig. 3 a) . Ten weeks later, the previously abnormal findings in the MRI had completely disappeared ( fig. 3 b) .
Discussion
As demonstrated, steroid therapy was effective in our case in the long-term follow-up. It is very rare to obtain improvement not only in MRI but also in posterior pituitary function [4, 5] . Normalization of PRL level was also obtained by PSL therapy, indicating that improvement of pituitary function was completed by PSL therapy in our case. IL-6, a cytokine delivered during inflammation [10] , also decreased after treatment, suggesting the improvement of inflammation in the pituitary. These data suggest that PSL and IL-6 are suitable as markers of the disease. Slow withdrawal of PSL 10 weeks after diabetes insipidus had disappeared seemed effective in this case; however, the reason for this is not clear.
There are many cases that require a transsphenoidal approach for diagnosis as reported previously [2, 3] . Considering that such an approach could have complications such as hypopituitarism, hemorrhage, infection and CSF rhinorrhea, pituitary biopsy is controversial. In our case, anterior pituitary function was almost preserved, and the inflammation was thought to be limited to the posterior pituitary, and the onset was acute. Thus steroid therapy based on noninvasive diagnosis was chosen. Furthermore, the therapy was beneficial to our patient and as such could be of benefit to those patients who may have risks of surgical damage. Hence we recommend that steroid therapy should be started at the initial stage of the disease if the side effects of steroids are not an issue. However, we also recommend meticulous observation for the emergence of lymphoma or other diseases after PSL therapy [11] .
Conclusion
This case shows that noninvasive diagnosis of LINH and appropriate steroid administration are efficacious and are recommended in the long-term follow-up.
